6 December 2024
MEDVIA is pleased to welcome four new members to our Board of Directors:
Hippo Dx – Dirk Loeckx 
Dirk Loeckx of Hippo Dx is replacing Carl Van Himbeeck of Cochlear on our Board of Directors. Dirk is CTO and QARA manager of Hippo Dx, a company fouinded in 2020 that offers automated skin prick tests for more accurate, faster and efficient allergy testing. Prior to Hippo, Dirk started icometrix, a provider of AI-driven imaging solutions to quantify and track neurological conditions through MRI and CT scans. He is also the co-founder and CSO of epihunter – a wearable EEG monitor and app that tracks epileptic events.
In addition to his entrepreneurial accomplishments, Dirk has authored over 150 scientific publications as well as multiple patents. He is a start-up mentor at KBC StartIt, imec.istart and EIT Health.
Surgi-Tec – Karin Scheerlinck 
Karin Scheerlinck of Surgi-Tec is replacing Jan Schrooten of Antleron on our Board. She is the co-founder and CEO of Surgi-Tec, a company specialized in the production of titanium implants for oral, maxillofacial and facial surgery, orthodontics and associated instruments. The company is now part of the Joosen Invest group.
Karin also provides consulting services for the Life Sciences & Care department at Private Maatschappij Vlaanderen (PMV), where she supports innovative start-ups and scale-ups. She is one of the founders of MedTech Flanders, and was Chair of the Board of Directors from 2015 until its integration into MEDVIA.
UZ Antwerpen – Marc Peeters 
Marc Peeters of UZ Antwerpen is replacing Marc Knoppen of UZ Brussel/VUB as the board member representing university hospitals. Marc is the CEO of UZA and a professor of oncology at the University of Antwerp.
Marc is the former head of the oncology department at UZA and coordinator of the Multidisciplinary Oncology Center Antwerp. His research has included the identification of molecular markers and therapy modulation in digestive tumors.
SCK-CEN – Koen Hasaers 
Koen Hasaers replaces Steven Latré of imec as one of our research institute representatives. Koen is the Director of Nuclear Medicine Applications at SCK-CEN, the Belgian nuclear research centre. He has a background in chemical, biomolecular and automation engineering as well as a decade of business development experience and over 15 years in the pharmaceutical industry.
Koen previously held directorial positions with Johnson & Johnson and Janssen Pharmaceuticals, and is the co-founder and former CEO of NovoPolymers, a developer of protectants for solar panel cells.
